Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers. | Transl Oncol | 2023 | 37713974 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Coronary Perivascular Adipose Tissue From End-Stage Heart Failure Patients Identifies SPP1+ Macrophage Subpopulation as a Target for Alleviating Fibrosis. | Arterioscler Thromb Vasc Biol | 2023 | 37706320 | PubTator, text mining | PubMed |
| Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases. | Cell Transplant | 2023 | 37698245 | PubTator, text mining | PubMed |
| Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells. | J Immunother Cancer | 2023 | 37678917 | PubTator, text mining | PubMed |
| Control of intracellular pH and bicarbonate by CO2 diffusion into human sperm. | Nat Commun | 2023 | 37669933 | PubTator, text mining | PubMed |
| Observational study of effects of pharyngeal stimulation by carbonated solution on repetitive voluntary swallowing in humans. | Medicine (Baltimore) | 2023 | 37653745 | PubTator, text mining | PubMed |
| Carbonic anhydrase IV in lizard chemical signals. | Sci Rep | 2023 | 37644071 | PubTator, text mining | PubMed |
| VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis. | Front Med (Lausanne) | 2023 | 37608823 | PubTator, text mining | PubMed |
| Cas4/1 dual nuclease activities enable prespacer maturation and directional integration in a type I-G CRISPR-Cas system. | J Biol Chem | 2023 | 37607619 | PubTator, text mining | PubMed |
| Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review). | Oncol Lett | 2023 | 37600346 | PubTator, text mining | PubMed |
| Effect of Colchicine Binding Site Inhibitors on the Tubulin Intersubunit Interaction. | ACS Omega | 2023 | 37599936 | PubTator, text mining | PubMed |
| A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy. | Cell Rep Med | 2023 | 37595589 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency. | J Enzyme Inhib Med Chem | 2023 | 37587873 | PubTator, text mining | PubMed |
| Applying machine learning to consumer wearable data for the early detection of complications after pediatric appendectomy. | NPJ Digit Med | 2023 | 37587211 | PubTator, text mining | PubMed |
| Release of cognitive and multimodal MRI data including real-world tasks and hippocampal subfield segmentations. | Sci Data | 2023 | 37587129 | PubTator, text mining | PubMed |
| The vascular perspective on acute and chronic lung disease. | J Clin Invest | 2023 | 37581311 | PubTator, text mining | PubMed |
| Volumes of hippocampal subfields suggest a continuum between schizophrenia, major depressive disorder and bipolar disorder. | Front Psychiatry | 2023 | 37547217 | PubTator, text mining | PubMed |
| Design, synthesis and antiproliferative screening of newly synthesized acrylate derivatives as potential anticancer agents. | RSC Adv | 2023 | 37546218 | PubTator, text mining | PubMed |
| Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. | Expert Opin Ther Pat | 2023 | 37545058 | PubTator, text mining | PubMed |
| Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma. | BMC Pulm Med | 2023 | 37537521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=11